Cited 0 times in
O8-4 KEYNOTE-042: 5-year update of first-line pembrolizumab in Asian patients with locally advanced/metastatic PD-L1-positive NSCLC
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.